Optos is expanding the optomap ultra-widefield (UWF) retinal imaging modalities available with the California FA device to further assist eyecare professionals in disease management and treatment planning.
In addition to optomap colour rg (red/green), sensory red-free, choroidal, autofluorescence (AF), fluorescein angiography (FAF) and indocyanine green angiography (ICGA) modalities, the company is pleased to announce the first ultra-widefield colour rgb (red/green/blue colour) image.
The company said the new image modality is captured simultaneous to the optomap colour red/green image, meaning a single capture delivers two colour ultra-widefield images.
Optos CEO Mr Rob Kennedy said the company is pleased to bring another image modality to its California FA device.
“The optimised colour palette used in the new optomap ultra-widefield colour red/green/blue image was created in close collaboration with eyecare professionals. The new image modality, in addition to our clinically validated optomap colour red/green images, provides additional retinal visualisation to our customers as they manage their patient’s treatment and ongoing care,” he said.
Optos said initial feedback from customers who saw the new RGB image at the American Society of Cataract and Refractive Surgery (ASCRS) meeting was positive.
Dr David Brown from Retina Consultants of Texas, lead author for a poster presented at the Association for Research in Vision and Ophthalmology (ARVO), said Optos imaging has revolutionised retina and is indispensable in the management of retinal vascular diseases.
“The optomap colour red/green/blue is particularly impressive in its ability to discern holes in peripheral lattice degeneration and retinoschisis which leads to immediate improvement to patient care. It is an exponential advancement in retinal imaging that will rapidly become the standard of care in our mutual fight against blindness,” he said.
Professor Paulo Stanga, director and vitreoretinal surgeon at The Retina Clinic, London said the newest ultra-widefield modality in California allows him to see a natural colour single capture ultra-widefield image.
“It has been exciting, in my day-to-day clinic, to see the improved detail of drusen in intermediate AMD patients, better characterise them, and track their progression. We can easily visualise the extent and severity of a macular epiretinal membrane and better grade diabetic retinopathy. I cannot envision my retina clinics without the assistance of Optos technology.”
Dr Steve Bloom, retina specialist at Bennett & Bloom Eye Center in Kentucky said including a blue wavelength to an optomap ultra-widefield image is most helpful for capturing a record of a patient’s fundus biomicroscopy.
“Looking at these red/green/blue colour ultra-widefield images makes me smile, and realise that in both health and disease, the retina remains a work of art.”
More reading
